Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies.

Antimicrobial Agents and Chemotherapy
P AngehrnR L Then

Abstract

Ro 13-9904, a new parenteral cephalosporin, was found to have high in vitro activity against Enterobacteriaceae and other gram-negative bacteria, including various isolates resistant to cefuroxime, cefamandole, cefoxitin, and cefazolin. It showed promising activity against Pseudomonas aeruginosa. Although inhibitory against Staphylococcus aureus at concentrations readily achievable in plasma, it was less potent against this pathogen than cefamandole, cefazolin, or cefuroxime. Isolates of Streptococcus faecalis were uniformly resistant to all the cephalosporins tested. Ro 13-9904 was more active than cefotaxime against Proteus mirabilis, Neisseria gonorrhoeae, Neisseria meningitidis, and Haemophilus influenzae, but less active against S. aureus. Ro 13-9904 was stable to various types of beta-lactamases. Its therapeutic efficacy against experimental septicemias in mice was equal to or slightly superior to that of cefotaxime and SCE-1365 when the antibiotics were administered in repeated subcutaneous doses after bacterial challenge. Cefoperazone, and particularly cefamandole nafate, cefazolin, and mezlocillin were less effective. Although structurally related to cefotaxime and SCE-1365, Ro 13-9904 was found to differ from them in ...Continue Reading

References

May 1, 1978·Antimicrobial Agents and Chemotherapy·P ActorJ A Weisbach
Aug 1, 1979·Antimicrobial Agents and Chemotherapy·H C NeuP Aswapokee
Dec 1, 1979·Antimicrobial Agents and Chemotherapy·N MatsubaraS Mitsuhashi
Dec 1, 1979·Antimicrobial Agents and Chemotherapy·R P MoutonM van Gestel
Jul 1, 1978·The Journal of Antimicrobial Chemotherapy·M H Richmond
Aug 1, 1979·Antimicrobial Agents and Chemotherapy·R LüthyW Siegenthaler
Nov 1, 1979·Antimicrobial Agents and Chemotherapy·T KamimuraS Kuwahara
Nov 1, 1977·Chemical & Pharmaceutical Bulletin·M OchiaiY Matsushita
Jun 1, 1978·Antimicrobial Agents and Chemotherapy·T SawaiS Yamagishi
Dec 1, 1978·Antimicrobial Agents and Chemotherapy·T B TjandramagaL Verbist
Dec 1, 1976·Antimicrobial Agents and Chemotherapy·T D Wilkins, S Chalgren
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Feb 1, 1980·Antimicrobial Agents and Chemotherapy·J N ParsonsM E Levison
Jul 1, 1980·The Journal of Antibiotics·R ReinerP J Probst

❮ Previous
Next ❯

Citations

Aug 1, 1991·Journal of Clinical Pharmacology·A TothT E Starzl
Jan 1, 1986·European Journal of Clinical Pharmacology·J R KoupK Stoeckel
Jan 1, 1982·European Journal of Clinical Pharmacology·P J McNamaraW H Ziegler
Jan 1, 1986·European Journal of Clinical Pharmacology·A A HolazoM Parsonnet
Jan 1, 1988·European Journal of Clinical Pharmacology·K StoeckelP J McNamara
Jun 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·P AngehrnR L Then
Feb 1, 1986·European Journal of Clinical Microbiology·K MachkaI Braveny
Oct 1, 1983·European Journal of Clinical Microbiology·W M Scheld
Oct 1, 1983·European Journal of Clinical Microbiology·K Machka, R Dietz
Oct 1, 1982·European Journal of Clinical Microbiology·E RubinsteinJ Spicehandler
Aug 1, 1981·Antimicrobial Agents and Chemotherapy·G BeskidP W Trown
Nov 1, 1981·Antimicrobial Agents and Chemotherapy·I H PatelS A Kaplan
Mar 1, 1982·Antimicrobial Agents and Chemotherapy·J S EpsteinG L Simon
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·J W GnannC G Cobbs
Jul 1, 1982·Antimicrobial Agents and Chemotherapy·M J MaslowJ J Rahal
Aug 1, 1982·Antimicrobial Agents and Chemotherapy·R D Rolfe, S M Finegold
Nov 1, 1982·Antimicrobial Agents and Chemotherapy·A A PollockJ J Rahal
Feb 1, 1983·Antimicrobial Agents and Chemotherapy·M J BittnerK B Crossley
Jan 1, 1984·Antimicrobial Agents and Chemotherapy·B L Congeni
Apr 1, 1984·Antimicrobial Agents and Chemotherapy·I H PatelS J Berman
Feb 1, 1985·Antimicrobial Agents and Chemotherapy·H H ZhouM Sun
Mar 1, 1986·Antimicrobial Agents and Chemotherapy·D H PitkinL J Nisbet
May 1, 1986·Antimicrobial Agents and Chemotherapy·G BenoniA Lechi
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·N H GeorgopapadakouG L Olson
Jun 1, 1983·The British Journal of Venereal Diseases·T R ZajdowiczW O Harrison
Apr 1, 1985·Genitourinary Medicine·K PanikabutraC Wongba
Jul 3, 2009·Biological & Pharmaceutical Bulletin·Kyoko FukumotoKazuyuki Ueno
Jan 1, 1990·Intensive Care Medicine·G HeinemeyerI Roots
Jan 1, 1985·Current Medical Research and Opinion·A M EmmersonM J Hall
Mar 1, 1993·Biopharmaceutics & Drug Disposition·F GenyM Galtier
Jul 19, 2006·Journal of Veterinary Pharmacology and Therapeutics·A GoudahA M Abd El-Aty
Apr 9, 1990·The American Journal of Medicine·S L Kaplan
Feb 1, 1986·American Journal of Surgery·D E Fry
Mar 1, 1988·Journal of Veterinary Pharmacology and Therapeutics·K A Caprile

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

Antimicrobial Agents and Chemotherapy
M SeddonR Livingston
Antimicrobial Agents and Chemotherapy
I H PatelS A Kaplan
Antimicrobial Agents and Chemotherapy
A M Hinkle, G P Bodey
© 2021 Meta ULC. All rights reserved